Greenstreet Yvonne
CIK 1446125
Transactions on file
91
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-22 | 2026-09-19 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Grant | 107 | $0.00 | — | open → |
| 2025-02-18 | 2025-02-14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 38 | $9.9K | -14.0% | open → |
| 2025-02-18 | 2025-02-14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 21 | $5.5K | -13.7% | open → |
| 2025-02-18 | 2025-02-14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 59 | $15.2K | -13.2% | open → |
| 2025-02-18 | 2025-02-14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 47 | $12.1K | -13.0% | open → |
| 2025-02-18 | 2025-02-14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 98 | $25.1K | -12.6% | open → |
| 2025-02-18 | 2025-02-14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 271 | $68.4K | -11.3% | open → |
| 2025-02-18 | 2025-02-14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 201 | $51.1K | -11.9% | open → |
| 2025-02-18 | 2025-02-14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 300 | $76.0K | -11.6% | open → |
| 2025-02-18 | 2025-02-14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 47 | $12.3K | -14.3% | open → |
| 2025-02-18 | 2025-02-14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 21 | $5.5K | -14.9% | open → |
| 2025-02-18 | 2025-02-14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 25 | $6.6K | -15.4% | open → |
| 2025-02-18 | 2025-02-13 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Grant | 3,859 | $0.00 | — | open → |
| 2025-02-18 | 2025-02-14 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 85 | $21.7K | -12.3% | open → |
| 2025-03-03 | 2025-02-28 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 127 | $30.4K | -6.3% | open → |
| 2025-03-03 | 2025-02-28 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 123 | $29.3K | -6.0% | open → |
| 2025-03-03 | 2025-02-28 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 158 | $37.4K | -5.3% | open → |
| 2025-03-03 | 2025-02-28 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 214 | $52.2K | -8.2% | open → |
| 2025-03-03 | 2025-02-28 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 284 | $68.3K | -6.8% | open → |
| 2025-03-03 | 2025-02-28 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 461 | $111.3K | -7.2% | open → |
| 2025-03-03 | 2025-02-28 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 1,093 | $265.0K | -7.6% | open → |
| 2025-03-03 | 2025-02-28 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 440 | $107.0K | -7.9% | open → |
| 2025-03-03 | 2025-02-27 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Exer. | 5,921 | $0.00 | — | open → |
| 2025-03-05 | 2025-03-03 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 791 | $193.3K | -8.3% | open → |
| 2025-03-05 | 2025-03-03 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 1,173 | $285.5K | -7.9% | open → |
| 2025-03-05 | 2025-03-03 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 1,068 | $258.9K | -7.6% | open → |
| 2025-03-05 | 2025-03-03 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Grant | 17,965 | $0.00 | — | open → |
| 2025-03-05 | 2025-03-03 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 4 | $993.44 | -9.8% | open → |
| 2025-03-05 | 2025-03-03 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 23 | $5.7K | -9.4% | open → |
| 2025-03-05 | 2025-03-03 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 238 | $58.6K | -9.0% | open → |
| 2025-03-05 | 2025-03-03 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 580 | $142.3K | -8.7% | open → |
| 2025-05-06 | 2025-05-02 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Gift | 41,311 | $0.00 | — | open → |
| 2025-05-19 | 2025-05-16 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Gift | 8,376 | $0.00 | — | open → |
| 2025-06-03 | 2025-05-30 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Exer. | 12,081 | $1.44M | +88.1% | open → |
| 2025-06-03 | 2025-05-30 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Exer. | 19,559 | $2.31M | +89.8% | open → |
| 2025-06-03 | 2025-05-30 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 25,469 | $7.74M | -26.3% | open → |
| 2025-06-03 | 2025-06-02 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Exer. | 12,080 | $1.44M | +88.1% | open → |
| 2025-06-03 | 2025-05-30 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 6,171 | $1.89M | -26.8% | open → |
| 2025-06-03 | 2025-06-02 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Exer. | 7,217 | $852.0K | +89.8% | open → |
| 2025-06-03 | 2025-06-02 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 19,297 | $5.90M | -26.8% | open → |
| 2025-12-01 | 2025-11-26 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Tax | 1,121 | $499.0K | -49.7% | open → |
| 2025-12-01 | 2025-11-26 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Exer. | 659 | $99.9K | +47.8% | open → |
| 2025-12-01 | 2025-11-26 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Exer. | 847 | $100.0K | +89.8% | open → |
| 2025-12-01 | 2025-11-26 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Exer. | 2,352 | $199.9K | +163.6% | open → |
| 2025-12-01 | 2025-11-26 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Exer. | 839 | $100.0K | +88.1% | open → |
| 2025-11-14 | 2025-11-13 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 261 | $119.0K | -50.9% | open → |
| 2025-11-14 | 2025-11-13 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 195 | $88.7K | -50.7% | open → |
| 2025-11-14 | 2025-11-13 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 881 | $400.0K | -50.7% | open → |
| 2025-11-14 | 2025-11-13 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 1,599 | $724.1K | -50.5% | open → |
| 2025-11-14 | 2025-11-13 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 1,702 | $769.2K | -50.4% | open → |
| 2025-11-14 | 2025-11-13 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 2,218 | $999.6K | -50.3% | open → |
| 2025-11-14 | 2025-11-13 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 1,477 | $664.7K | -50.2% | open → |
| 2025-11-14 | 2025-11-13 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 1,013 | $454.6K | -50.1% | open → |
| 2025-11-14 | 2025-11-13 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 654 | $292.8K | -50.0% | open → |
| 2025-11-14 | 2025-11-13 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Exer. | 10,000 | $1.19M | +88.1% | open → |
| 2025-11-14 | 2025-11-12 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 430 | $197.1K | -51.1% | open → |
| 2025-11-14 | 2025-11-12 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 604 | $276.5K | -51.1% | open → |
| 2025-11-14 | 2025-11-12 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 2,420 | $1.11M | -50.9% | open → |
| 2025-11-14 | 2025-11-12 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 3,406 | $1.55M | -50.8% | open → |
| 2025-11-14 | 2025-11-12 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 1,960 | $891.5K | -50.7% | open → |
| 2025-11-14 | 2025-11-12 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 1,069 | $484.8K | -50.6% | open → |
| 2025-11-14 | 2025-11-12 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 1,210 | $547.4K | -50.5% | open → |
| 2025-11-14 | 2025-11-12 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 1,255 | $566.2K | -50.3% | open → |
| 2025-11-14 | 2025-11-12 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 453 | $203.9K | -50.2% | open → |
| 2025-11-14 | 2025-11-12 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 2,132 | $957.6K | -50.1% | open → |
| 2025-11-14 | 2025-11-12 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 711 | $318.6K | -50.0% | open → |
| 2025-11-14 | 2025-11-12 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Exer. | 15,000 | $1.79M | +88.1% | open → |
| 2025-11-14 | 2025-11-12 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Exer. | 650 | $27.4K | +430.6% | open → |
| 2025-10-03 | 2025-10-02 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 9 | $4.1K | -51.0% | open → |
| 2025-10-03 | 2025-10-02 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 446 | $204.0K | -51.0% | open → |
| 2025-10-03 | 2025-10-02 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 221 | $100.7K | -50.9% | open → |
| 2025-10-03 | 2025-10-02 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 741 | $337.0K | -50.7% | open → |
| 2025-10-03 | 2025-10-02 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 999 | $453.3K | -50.6% | open → |
| 2025-10-03 | 2025-10-02 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 2,029 | $918.5K | -50.5% | open → |
| 2025-10-03 | 2025-10-02 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 1,010 | $456.4K | -50.4% | open → |
| 2025-10-03 | 2025-10-02 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 1,642 | $740.2K | -50.3% | open → |
| 2025-10-03 | 2025-10-02 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 758 | $340.9K | -50.2% | open → |
| 2025-10-03 | 2025-10-02 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 548 | $245.9K | -50.1% | open → |
| 2025-10-03 | 2025-10-02 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 171 | $76.6K | -50.0% | open → |
| 2025-10-03 | 2025-10-02 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 350 | $156.3K | -49.8% | open → |
| 2025-10-03 | 2025-10-01 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Grant | 14,252 | $0.00 | — | open → |
| 2025-10-03 | 2025-10-01 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Grant | 3,860 | $0.00 | — | open → |
| 2025-08-19 | 2025-08-18 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 195 | $87.9K | -50.3% | open → |
| 2025-08-19 | 2025-08-15 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Grant | 14,252 | $0.00 | — | open → |
| 2025-08-19 | 2025-08-18 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 194 | $86.9K | -50.0% | open → |
| 2025-08-19 | 2025-08-18 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 450 | $202.5K | -50.2% | open → |
| 2025-08-19 | 2025-08-18 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 60 | $27.3K | -50.9% | open → |
| 2025-08-19 | 2025-08-18 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 514 | $232.3K | -50.4% | open → |
| 2025-08-19 | 2025-08-18 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 1,646 | $745.6K | -50.5% | open → |
| 2025-08-19 | 2025-08-18 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 2,716 | $1.23M | -50.7% | open → |
| 2025-08-19 | 2025-08-18 | ALNY ALNYLAM PHARMACEUTICALS, INC. | OfficerDirector Chief Executive Officer | Sale | 1,204 | $547.6K | -50.7% | open → |
